共 50 条
- [21] Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients [J]. Breast Cancer Research and Treatment, 2017, 165 : 659 - 668
- [22] Inhibition of aromatase (estrogen synthase) activity by several flavonoids [J]. FASEB JOURNAL, 2006, 20 (04): : A355 - A355
- [25] Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2013, 59 (03): : 217 - 217
- [26] Aromatase inhibitor strategies in metastatic breast cancer [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2009, 1 : 67 - 72
- [27] The aromatase inhibitor exemestane in the treatment of breast cancer [J]. XI INTERNATIONAL CONGRESS OF SENOLOGY, 2000, : 67 - 75
- [28] Safety of aromatase inhibitor therapy in breast cancer [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1201 - 1211
- [29] AROMATASE-ACTIVITY IN BREAST-TISSUE [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 39 (5B): : 783 - 790
- [30] Aromatase activity and expression in breast cancer and benign breast tissue stromal cells [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01): : 200 - 208